摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(2-Fluoro-benzenesulfonyl)-octahydro-pyrido[1,2-a]pyrazin-6-one | 1182733-30-7

中文名称
——
中文别名
——
英文名称
2-(2-Fluoro-benzenesulfonyl)-octahydro-pyrido[1,2-a]pyrazin-6-one
英文别名
2-(2-fluorophenyl)sulfonyl-3,4,7,8,9,9a-hexahydro-1H-pyrido[1,2-a]pyrazin-6-one
2-(2-Fluoro-benzenesulfonyl)-octahydro-pyrido[1,2-a]pyrazin-6-one化学式
CAS
1182733-30-7
化学式
C14H17FN2O3S
mdl
——
分子量
312.365
InChiKey
HAZBCZJFCFJOJU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.9
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    66.1
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    描述:
    2-氟苯磺酰氯八氢吡啶并〔1,2-A〕吡嗪-6-酮三乙胺 作用下, 以 DCM 、 乙腈 为溶剂, 以44%的产率得到2-(2-Fluoro-benzenesulfonyl)-octahydro-pyrido[1,2-a]pyrazin-6-one
    参考文献:
    名称:
    Nitrogen-containing bicyclic compounds active on chronic pain conditions
    摘要:
    公开号:
    EP2098526B1
点击查看最新优质反应信息

文献信息

  • Substituted pyrrolo[1,2-A] pyrazines, compositions containing these, processes of making these, and uses thereof
    申请人:Neurotune AG
    公开号:US08334286B2
    公开(公告)日:2012-12-18
    The invention refers to compounds of general formula (I) wherein the R groups are, independently, H, C1-6alkyl, aryl, CF3; Y is CH2, C═O; X is bond, C═O, SO2, or C═N—CN; m is 0, 1; n is 0, 1; A is a heterocycle, or a phenyl group optionally substituted as defined in the specification. The compounds are active on chronic pain conditions of different origin; they can be administered alone or with other drugs. Most of these compounds are new. The invention include a process to prepare said compounds, and pharmaceutical compositions suitable for their administration to a patient.
    本发明涉及一般式(I)的化合物,其中R基团是独立的H,C1-6烷基,芳基,CF3; Y是CH2,C═O; X是键,C═O,SO2或C═N—CN; m为0,1; n为0,1; A是杂环或苯基,可选地在规范中定义的取代基。这些化合物对不同来源的慢性疼痛病症具有活性;它们可以单独或与其他药物一起使用。大多数这些化合物都是新的。本发明包括制备所述化合物的方法,以及适合于向患者施用的制药组合物。
  • NITROGEN-CONTAINING BYCYCLIC COMPOUNDS ACTIVE ON CHRONIC PAIN CONDITIONS
    申请人:Ghelardini Carla
    公开号:US20110015200A1
    公开(公告)日:2011-01-20
    The invention refers to compounds of general formula (I) wherein the R groups are, independently, H, C 1-6 alkyl, aryl, CF 3 ; Y is CH 2 , C═O; X is bond, C═O, SO 2 , or C═N—CN; m is 0, 1; n is 0, 1; A is a heterocycle, or a phenyl group optionally substituted as defined in the specification. The compounds are active on chronic pain conditions of different origin; they can be administered alone or with other drugs. Most of these compounds are new. The invention include a process to prepare said compounds, and pharmaceutical compositions suitable for their administration to a patient.
    该发明涉及一般式(I)的化合物,其中R基独立地为H,C1-6烷基,芳基,CF3;Y为CH2,C═O;X为键,C═O,SO2或C═N—CN;m为0,1;n为0,1;A为杂环或苯基,可选地取代如说明书所定义。这些化合物对不同起源的慢性疼痛症状具有活性,它们可以单独或与其他药物一起使用。其中大多数化合物都是新的。该发明包括一种制备上述化合物的方法以及适用于其向患者的管理的制药组合物。
  • US8334286B2
    申请人:——
    公开号:US8334286B2
    公开(公告)日:2012-12-18
  • [EN] NITROGEN-CONTAINING BYCYCLIC COMPOUNDS ACTIVE ON CHRONIC PAIN CONDITIONS<br/>[FR] COMPOSÉS BICYCLIQUES CONTENANT DE L'AZOTE AGISSANT SUR LES ÉTATS DE DOULEUR CHRONIQUE
    申请人:NEUROTUNE AG
    公开号:WO2009103176A1
    公开(公告)日:2009-08-27
    The invention refers to compounds of general formula (I) wherein the R groups are, independently, H, C1-6alkyl, aryl, CF3; Y is CH2, C=O; X is bond, C=O, SO2, or C=N-CN; m is 0, 1; n is 0, 1; A is a heterocycle, or a phenyl group optionally substituted as defined in the specification. The compounds are active on chronic pain conditions of different origin; they can be administered alone or with other drugs. Most of these compounds are new. The invention include a process to prepare said compounds, and pharmaceutical compositions suitable for their administration to a patient.
查看更多

同类化合物

麦可弗汀A 罗哌卡因杂质 六氢-2-甲基-2H-吡啶并[1,2-a]吡嗪-1,6-二酮 八氢吡啶并〔1,2-A〕吡嗪-6-酮 八氢吡啶并[1,2-a]吡嗪 八氢-吡啶并[1,2-A]吡嗪-4-酮盐酸盐 八氢-6H-吡啶并[1,2-a]吡嗪-6-酮盐酸盐 八氢-3-甲基-2H-吡啶并[1,2-a]吡嗪 八氢-2H-吡啶并[1,2-a]吡嗪二盐酸盐 八氢-2H-吡啶并[1,2-a]吡嗪-6-甲醇 7-甲氧基辛a氢-2H-吡啶并[1,2-a]吡嗪-2-胺 7-乙基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 6-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 4H-吡唑[1,2-A]吡嗪-4-八氢酮 3-甲基八氢-2H-吡啶并[1,2-a]吡嗪-2-胺 2-苄基八氢-1H-吡啶并[1,2-a]吡嗪 2-硝基八氢-2H-吡啶并[1,2-a]吡嗪 2-乙基六氢-2H-吡啶并[1,2-a]吡嗪-1(6H)-酮 2-(9-甲基-3,9-二氮杂双环[3.3.1]壬-3-基)乙胺 2-(4-甲硫基唑-5-基)乙基丁酸酯 2,3,4,6,7,8,9,9alpha-八氢-1H-吡啶并[1,2-a]吡嗪-3-基甲醇 1,1'-联苯基,2-乙基-5-甲氧基- (R)-八氢吡啶并[1,2-A〕吡嗪二盐酸盐 (9aS)-八氢-4H-吡啶并[1,2-a]吡嗪-4-酮 (9aR)-八氢-2H-吡啶并[1,2-a]吡嗪 (9SS)-八氢-2-吡啶-吡嗪盐酸盐[1,2-A] (7r,9as)-八氢-2H-吡啶并[1,2-a]吡嗪-7-甲醇 (3S,6S)-3-苄基-1,4-二氮杂双环[4.4.0]癸烷-2,5-二酮 ((7S,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-7-基)甲醇 ((6R,9as)-八氢-1H-吡啶并[1,2-a]吡嗪-6-基)甲醇 cyclo-(D-Leu-D-Pip) (3S,9aR)-hexahydro-3-methyl-6H-pyrido[1,2-a]pyrazine-1,4-dione (9aS)-2-benzyl-1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine 3-[3-(1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-(2-chloro-3-fluoroanilino)cyclobut-3-ene-1,2-dione (7R,9aS)-trans-7-(3-morpholin-4-ylmethylphenoxymethyl)-octahydro-pyrido[1,2-a]pyrazine-2-carboxylic acid tert-butyl ester 3-[3-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazine-2-carbonyl)-2-methoxyanilino]-4-[[(1R)-1-phenylpropyl]amino]cyclobut-3-ene-1,2-dione 3-Chinolizidin-1-yl-2-methylindol 2-propyl-octahydro-pyrido[1,2-c][1,3,6]oxadiazocine (8R,9aS)-2-benzyl-3,3-dioxido-1-oxooctahydropyrrolo[2,1-d][1,2,5]thiadiazepin-8-yl cyclohexylcarbamate 2-(5-Amino-2-methoxy-phenyl)-hexahydro-pyrido[1,2-a]pyrazin-3-one 14α-hydroxy-15α-methyl-16β-methylsulfinyl-17-oxomarcfortine A (1S,7S,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one (4-Aminophenyl)-(1,3,4,6,7,8,9,9a-octahydropyrido[1,2-a]pyrazin-2-yl)methanone 3-Benzylaminomethyl-chinolizidin rac-(4aR,8aR)-1-(piperidin-3-yl)-decahydroquinoline (1S,7R,10S)-12-Acetyl-9-thia-3,12-diaza-tricyclo[8.2.1.03,7]tridecan-2-one N-((1R,2S,5R)-2-((S)-3-amino-2-oxopyrrolidin-1-yl)-5-(isopropylamino)cyclohexyl)acetamide 2-tert-butylperhydroimidazolo<3,4-a>pyridine 1,3,4,6,7,8,9,9a-Octahydropyrido[1,2-a]pyrazin-2-yl-(2-chloro-5-phenylthiophen-3-yl)methanone 3-[2-oxo-2-[5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5,9-diazaspiro[2.6]nonan-9-yl]ethyl]thiazolidine-2,4-dione